HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $329,000 | +8.9% | 2,815 | -4.3% | 0.00% | 0.0% |
| Q2 2023 | $302,000 | -24.9% | 2,940 | -20.2% | 0.00% | 0.0% |
| Q1 2023 | $402,000 | -70.2% | 3,683 | -68.9% | 0.00% | -66.7% |
| Q4 2022 | $1,350,000 | -28.3% | 11,829 | -61.1% | 0.00% | -40.0% |
| Q3 2022 | $1,884,000 | -21.6% | 30,438 | +1.1% | 0.01% | -16.7% |
| Q2 2022 | $2,404,000 | -26.5% | 30,109 | -3.1% | 0.01% | -14.3% |
| Q1 2022 | $3,271,000 | -16.3% | 31,083 | -14.3% | 0.01% | -22.2% |
| Q4 2021 | $3,908,000 | -8.0% | 36,289 | -6.4% | 0.01% | -18.2% |
| Q3 2021 | $4,247,000 | +26.2% | 38,764 | +7.9% | 0.01% | +10.0% |
| Q2 2021 | $3,366,000 | +5.7% | 35,930 | +3.9% | 0.01% | 0.0% |
| Q1 2021 | $3,185,000 | +29.2% | 34,581 | +2.7% | 0.01% | 0.0% |
| Q4 2020 | $2,465,000 | +10.7% | 33,673 | +17.8% | 0.01% | -9.1% |
| Q3 2020 | $2,226,000 | +350.6% | 28,574 | +221.2% | 0.01% | +266.7% |
| Q2 2020 | $494,000 | – | 8,896 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |